About
Technology
Issues
FAQ
Links
Official Page
A157 REAL-WORLD TIGHT OBJECTIVE MONITORING WITH ADALIMUMAB LEADS TO EARLIER DOSE OPTIMIZATION AND HIGHER CLINICAL REMISSION RATES AT 12 MONTHS.
site/software ©
exaly
; All materials licenced under
CC by-SA
.